Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: Relationship to gender, pubertal development, growth, insulin, and nutritional status

Metabolism: Clinical and Experimental

Volumn 46, Issue 8, 1997, Pages 862-871

  Falorni, Adriano ^a   Bini, Vittorio ^b   Cabiati, Gabriele ^b   Papi, Francesco ^b   Arzano, Sergio ^b   Celi, Federica ^b   Sanasi, Massimo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROCOLLAGEN; PROTEIN PRECURSOR; SOMATOMEDIN;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; MALE; NUTRITIONAL STATUS; OBESITY; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; SEXUAL DEVELOPMENT;

EID: 0030835730     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90071-8     Document Type: Article

References (66)

1. Garn SM, Haskell JA: Fat and growth during childhood. Science 130:1711-1712, 1959
2. Hammar SL, Campbell MM, Campbell VA, et al: An interdisciplinary study of adolescent obesity. J Pediatr 80:373-383, 1972
3. Bernfeld J, Dahan O: Croissance et développement de l'énfant obèse. Etude longitudinale. Rev Fr Endocrinol Clin 17:141-164, 1976
4. Forbes GB: Nutrition and growth. J Pediatr 91:40-42, 1977
5. Laron Z, Ben-Dan, Shrem M, et al: Puberty in simple obese boys and girls, in Cacciari E, Laron Z, Raiti S (eds): Obesity in Childhood. London, UK, Academic, 1978, pp 29-40
6. Paige DM: Obesity in childhood and adolescence. Postgrad Med 79:233-245, 1986
7. Minuto F, Barreca A, Del Monte P, et al: Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-1 secretion in obese subjects during puberty. J Endocrinol Invest 11:489-495, 1988
8. Vignolo M, Naselli A, Di Battista E, et al: Growth and development in simple obesity. Eur J Pediatr 147:242-244, 1988
9. De Simone M, Farello G, Palumbo M, et al: Growth charts, growth velocity and bone development in childhood obesity. Int J Obes 19:851-856, 1995
10. Garn S, Clark DC: Nutrition, growth, development and maturation: Findings from the ten-state nutrition survey of 1968-1970. Pediatrics 56:306-319, 1975
11. Meistas MT, Foster GV, Margolis S, et al: Integrated concentration of GH, insulin, C-peptide and prolactin in human obesity. Metabolism 31:1224-1228, 1982
12. Loche S, Cappa M, Borrelli P, et al: Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: Evidence for somatomedin-C mediated inhibition. Clin Endocrinol (Oxf) 27:145-153, 1987
13. Rosskamp R, Becker M, Soetadji S: Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children. Eur J Pediatr 146:48-50, 1987
14. Chalew SA, Lozano RA, Armour KM, et al: Reduction of plasma insulin levels does not restore integrated concentration of growth hormone to normal in obese children. Int J Obes 16:459-463, 1992
15. Hochberg Z, Hertz P, Colin V, et al: The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGE-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 41:106-112, 1992
16. Loche S, Balzano S, Bozzola M, et al: Secretion of growth hormone releasing hormone in obese children. J Endocrinol Invest 15:453-457, 1992
17. Vanderschueren-Lodeweyckx M: The effect of simple obesity on growth and growth hormone. Horm Res 40:23-30, 1993
18. Rasmussen MH, Juul A, Kjems LL, et al: Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J Clin Endocrinol Metab 80:796-801, 1995
19. Rasmussen MH, Hvidberg A, Juul A, et al: Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 80:1407-1415, 1995
20. Van Vliet G, Bosson D, Rummens E, et al: Evidence against growth hormone releasing factor deficiency in children with idiopathic obesity. Acta Endocrinol (Copenh) 279:403-408, 1986 (suppl)
21. Caufriez A, Golstein J, Lebrun P, et al: Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects. Clin Endocrinol (Oxf) 20:65-70, 1984
22. Grzywa M: Serum somatomedin activity and growth-hormone levels in obese men: Dependence on degree of obesity and hyperlipidemia. Exp Clin Endocrinol 88:325-330, 1986
23. Copeland KC, Colletti RB, Devlin JT, et al: The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 39:584-587, 1990
24. Mårin P, Kvist H, Lindstedt G, et al: Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes 17:83-89, 1993
25. Frystik J, Vestbo E, Skjærbaek, et al: Free insulin-like growth factors in human obesity. Metabolism 44:37-44, 1995 (suppl 4)
26. Conover CA: Regulation of IGFBP-3 synthesis by insulin and IGF-I in cultured bovine fibroblasts. Endocrinology 126:3139-3145, 1990
27. Martin JL, Baxter RC: Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 261:8754-8760, 1986
28. Blum WF, Ranke MB, Kietzman K, et al: A specific radioimmunoassay for the growth-hormone (GH) dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298, 1990
29. Blum WF: Insulin-like growth factors and their binding protein, in Ranke MB (ed): Functional Endocrinology Diagnostics in Children and Adolescents. Mannheim, Germany, Verlag, 1992, pp 102-117
30. Jones J, Clemmons D: Insulin-like growth factors and their binding proteins: Biological action. Endocr Rev 16:3-34, 1995
31. Robins SP: Biochemical markers for assessing skeletal growth. Eur J Clin Nutr 48:8199-8209, 1994 (suppl 1)
32. Graham MF: The use of serum levels of procollagen propeptides to predict growth velocity. J Pediatr Gastroenterol Nutr 2:143-145, 1989
33. Trivedi P, Risteli J, Risteli L, et al: Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children with growth disorders. Pediatr Res 30:276-280, 1991
34. Parfitt AM, Simon LS, Villaneuva AR, et al: Procollagen type I carboxyterminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac-bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 2:427-436, 1987
35. Saggese G, Bertelloni S, Baroncelli GI, et al: Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr 151:764-768, 1992
36. Melkko J, Niemi S, Risteli L, et al: Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332, 1990
37. Allen DB, Goldberg BD: Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children. Pediatrics 89:416-421, 1992
38. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 51:170-176, 1976
39. Rolland-Cachera MF, Cole TJ, Sempé M, et al: Body mass index variations: Gentiles from birth to 87 years. Eur J Clin Nutr 45:13-21, 1991
40. Tanner JM, Whitehouse RH: Revised standards for triceps and subscapular skinfolds in British children. Arch Dis Child 50:142-145, 1975
41. Cole TJ: A method for assessing age-standardized weight for height in children seen cross sectionally. Ann Hum Biol 6:249-268, 1979
42. Daughaday WH, Mariz IK, Blethen SL: Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab 51:781-788, 1980
43. Bassett NS, Oliver MH, Breier BH, et al: The effect of maternal starvation on plasma insulin-like growth factor I concentrations in the late gestation ovine fetus. Pediatr Res 27:401-404, 1990
44. Breier BH, Gallaher BW, Gluckman PD: Radioimmunoassay for insulin-like growth factor I: Solutions to some potential problems and pitfalls. J Endocrinol 128:347-357, 1990
45. Bang P: Valid measurement of total IGF concentrations in biological fluids: Recommendations from the 3rd International Symposium on Insulin-Like Growth Factors. Eur J Endocrinol 132:338-339, 1995
46. Hintz RL, Lui F: Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab 45:988-995, 1977
47. Cole TJ: Fitting smoothed centile curves to reference data (with discussion). J R Stat Soc A 151:385-418, 1988
48. Cole YJ, Green PJ: Smoothing reference centile curves: The LMS method and penalized likelihood. Stat Med 11:1305-1319, 1992
49. Delamarre-van De Waal HA, Martens F, Odnik RJH: Type I procollagen level in relation to growth hormone, SM-C and sex steroids throughout normal puberty. Horm Res 35:41-43, 1991 (suppl 2)
50. Carey DE, Goldberg B, Ratzen SK, et al: Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone. Pediatr Res 19:8-11, 1985
51. Hyams JS, Carey DE, Leichtner AM, et al: Type I procollagen as a biochemical marker of growth in children with inflammatory bowel disease. J Pediatr 109:619-624, 1986
52. Hassager C, Jensen LT, Johansen JS, et al: The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: The effect of nandrolone decanoate and female sex hormones. Metabolism 40:205-208, 1991
53. Jensen LT, Jorgensen OL, Risteli J, et al: Type I and III procollagen propeptides in growth hormone-deficient patients: Effects of increasing doses of GH. Acta Endocrinol (Copenh) 124:278-282, 1991
54. Juul A, Bang P, Hertel NT, et al: Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752, 1994
55. Cordido F, Casanueva FF, Vidal JI, et al: Study of insulin-like growth factor I in human obesity. Horm Res 36:187-191, 1991
56. Blum WF, Albertsson-Wikland K, Rosberg S, et al: Serum levels of insulin-like growth factor-I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76:1610-1616, 1993
57. Blum WF, Ranke MB: Plasma IGF-BP3 levels as clinical indicators, in Spencer EM (ed): Modern Concepts of Insulin-Like Growth Factors. Amsterdam, The Netherlands, Elsevier, 1990, pp 381-393
58. Martha PM Jr, Reiter EO, Dv̀ila N, et al: Serum growth hormone (GH)-binding protein/receptor: An important determinant of GH responsiveness. J Clin Endocrinol Metab 75:1464-1469, 1992
59. Martha PM Jr, Reiter EO, Dàvila N, et al: The role of body mass in the response to growth hormone therapy. J Clin Endocrinol Metab 75:1464-1469, 1992
60. Tollet P, Enberg B, Mode A: Growth hormone regulation of cytochrome P-450IIC12, IGF-I and GH receptor messenger RNA expression in primary rat hepatocytes: A hormonal interplay with insulin, IGF-I, and a thyroid hormone. Mol Endocrinol 4:1934-1942, 1990
61. Clemmons DR, Underwood LE, Maes RN: Use of plasma somatomedin C/insulin-like growth factor I measurement to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 41:191-198, 1985
62. Soliman A, Hassan A, Aref M, et al; Serum IGF-I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20:1122-1130, 1986
63. Oster MH, Fielder PJ, Levin N, et al: Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. J Clin Invest 95:2258-2265, 1995
64. Nguyen-Yamamoto L, Deal CL, Finkelstein JA, et al: Hormonal control of growth in the genetically obese Zucker rat. I. Linear growth, plasma insulin-like growth factor-I (IGF-I) and IGF-binding proteins. Endocrinology 134:1382-1388, 1994
65. Juul A, Dalgaard P, Blum WF, et al: Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-3, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534-2542, 1995
66. Bang P, Brismar K, Rosenfeld RG, et al: Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J Clin Endocrinol Metab 78:960-967, 1994